Materials and Methods: In this single arm, open-labeled study, 13 patients were given
nebivolol, 5 mg orally once daily for 15 days. Primary outcome was change in central aortic …

Objectives Some β-blockers are less effective in reducing central blood pressure than other
antihypertensive drugs, which may explain the higher rate of events in subjects randomized …

Measurement of blood pressure (BP) using a brachial cuff sphygmomanometer is
universally accepted for the diagnosis of hypertension and prediction of cardiovascular …

Nebivolol is a third generation beta-blocker, which can be distinguished from other beta-
blockers by its hemodynamic profile. It combines beta-adrenergic blocking activity with a …

Introduction. The main objective was to compare the mean change in augmentation index of
hypertensive patients treated with nebivolol or atenolol. Methods. Multicenter, double-blind …

Background There is conflicting information with regard to the effect of β-blockers on arterial
stiffness and wave reflection. We compared a vasodilating β-blocker, nebivolol, with …

BACKGROUND: Arterial hypertension affects endothelial function and arterial stiffness. The
angiotensin (AT1) receptor antagonist irbesartan improves endothelial function and arterial …

The aim of this study was to investigate the effects of the vasodilating β-blocker nebivolol
and the cardioselective β-blocker metoprolol succinate on aortic blood pressure and left …

Aortic elastic properties Page 1 Herz 2012 · 38:299–305 DOI 10.1007/s00059-012-3695-9
Received: 18 April 2012 Revised: 4 September 2012 Accepted: 7 September 2012 …

We aim to determine whether nebivolol has a better effect on endothelial dysfunction
compared with other β-blockers or other classes of antihypertensive drugs. Searches of the …